Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2011-08-30
2011-08-30
Graser, Jennifer (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S234100, C424S197110, C435S243000, C435S252100
Reexamination Certificate
active
08007817
ABSTRACT:
The present invention relates to methods and compositions for treatment of microbial infections and for the enhancement of resistance to infection. The invention comprises administration of an effective amount of bacterial lysate compositions for the treatment of pathological conditions of microbial infections. The present invention can also be used to enhance the immune system to prevent infections by the administration of an effective amount of the compositions.
REFERENCES:
patent: 159192 (1875-01-01), Leiter
patent: 3855197 (1974-12-01), Hirsch et al.
patent: 4485045 (1984-11-01), Regen
patent: 4544545 (1985-10-01), Ryan et al.
patent: 4659558 (1987-04-01), Urquhart et al.
patent: 4668218 (1987-05-01), Virtanen
patent: 5013556 (1991-05-01), Woodle et al.
patent: 5458135 (1995-10-01), Patton et al.
patent: 5514097 (1996-05-01), Knauer
patent: 5643214 (1997-07-01), Marshall et al.
patent: 6027734 (2000-02-01), Briles et al.
patent: 6294177 (2001-09-01), Fattom
patent: 6929798 (2005-08-01), Pillich et al.
patent: 7329409 (2008-02-01), Pillich et al.
patent: 7648707 (2010-01-01), Pillich et al.
patent: 2550707 (1983-04-01), None
patent: WO94/16970 (1994-08-01), None
patent: WO97/25086 (1997-07-01), None
patent: WO98/35888 (1998-08-01), None
Ruah et al (Adv,in Therapy, Jul./Aug. 2001, vol. 18(4)).
Ruedl et al (Clin. Diagnost. Lab. Immunol. 1994, pp. 150-154).
Puigdollers et al (Respiration, 1980, 40 : 142-149).
Carneiro, Celia R.W., et al. (2004)Microbes and Infection6: 604-608.
Esber, Henry J. et al. (1981) Specific and nonspecific immune resistance enhancing activity of staphage lysate.J. Immunopharmacology, 3(1): 79-92.
Esber, Henry J. et al. (1985) Staphage lysate: an immunomodulator of the primary immune response in mice.Immunopharmacology. 10(2):77-82.
Ganfield, DJ et al. (1985) Stimulation of Human Lymphocytes with Components of the Staphyloccal Vaccine. Staphage Lysate.Federation Proceedings44: 3598.
Kosorok et al. (2001) Acceleration of Lung Disease in Children with Cystic Fibrosis afterPseudomonas aeruginosaAcquisition.Pediatric Pulmonology. 32: 277-287.
Puigdollers et al. (1980) Immunoglobulin Production in Man Stimulated by an Orally Administered Bacterial Lysate.Respiration. 40: 142-149.
Ruah et al. (2001) Efficacy of a Polyvalent Bacterial Lysate in Children with Recurrent Respiratory Tract Infections.Advances in Therapy. 18(4): 151-162.
Ruedl et al. (1994) Immune Response in the Lungs Following Oral Immunization with Bacterial Lysates of Respiratory Pathogens.Clinical and Diagnostic Laboratory Immunology. 1(2): 150-154.
Rossi et al. (2003) Naturally Occurring Immune Response Against Bacteria Commonly Involved in Upper Respiratory Tract Infections: Analysis of the Antigenspecific Salivary IgA Levels.Immunology Letters86: 85-91.
Sekaninova, G. et al. (1999)Pseudomonas aeruginosaphage lysate as an immunobiological agent. 1. Selection ofPseudomonas aeruginosaclinical strains for phage lysate preparation.Folia Microbial44(1): 93-97.
West et al. (2002) Respiratory Infections withPseudomonas aeruginosain Children with Cystic Fibrosis.JAMA287(22): 2958-2967.
Balcarek John
Pillich Jiri
Ballard Spahr LLP
Graser Jennifer
Immunology Laboratories, Inc.
LandOfFree
Compositions and methods for treating microbial infections does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for treating microbial infections, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for treating microbial infections will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2764939